May 2019 Market Review
Following is a summary of the markets and our funds’ performance for the month of May 2019, provided by our Chief Investment Strategist David A. Klassen.
UCF Leads a Resolution that Generates 79.7% Support from Shareholders
UCF is celebrating the very successful campaign at pharmaceutical company Mallinckrodt, where a resolution that UCF sponsored on lobbying disclosures generated 79.7% support from the company’s shareholders.
April 2019 Market Review
Following is a summary of the markets and our funds’ performance for the month of April 2019, provided by our Chief Investment Strategist David A. Klassen.